在未被认可的罕见瘤患者中选择严重高血压的外科治疗方法:病例报告
Noah Kevin McGreal1,2, Zachary Dylan Winnegrad1,2, Gregory Joseph Diorio1,2
1Cooper Medical School of Rowan University, Camden, New Jersey, USA.
Case reports in urology
|September 24, 2025
概括
排球细胞瘤 (JCTs) 是一种罕见的产生宁的脏质量,可以导致严重的高血压. 手术切除JCT可以显著改善高血压,减少药物需求.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 排球细胞瘤 (JCTs) 或瘤是一种罕见的瘤.
- 虽然通常是良性的,JCT可以表现出内分泌活性,导致严重的高血压和电解质障碍.
- 记录的病例不到150例,这突显了它们的罕见性.
研究的目的:
- 报告一个被诊断为JCT的复杂囊性质病例.
- 强调JCT的诊断和治疗方面的考虑,特别是在高血压患者中.
- 要突出一个JCT的成功手术管理.
主要方法:
- 一个40岁的男性患有高血压和复杂的囊性质病例报告.
- 质的手术切除. 质的手术切除.
- 术后病理证实了JCT.
主要成果:
- 患者出现了耐药性高血压和复杂的囊性质.
- 病理学证实了JCT的诊断.
- 经过手术切除后,患者的高血压明显改善,药物需求减少.
结论:
- 在对质的差异诊断中应考虑联合试验,特别是在高血压患者中.
- 联合治疗的外科手术可以有效地管理相关的内分泌活动,如高血压.
- 这一案例强调了在患有质的高血压患者中考虑JCT的重要性.
相关概念视频
Urinary Tract Calculi VI: Surgical Management
382
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
382
Kidney Transplant II: Surgical Procedure
320
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
320
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
936
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
936


